Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Wilms Tumor 1Sarcoma 1Peripheral Nervous System Diseases 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia 1Kidney Neoplasms 1Hematologic Neoplasms 1Fanconi Anemia 1Dendritic Cell Sarcoma, Interdigitating 1Carcinoma, Squamous Cell 1Burkitt Lymphoma 1Body Weight 1

Interventions

fludarabine phosphate 19Peripheral Blood Stem Cell Transplantation 15Cyclophosphamide 15Whole-Body Irradiation 14Tacrolimus 13Mycophenolic Acid 13Busulfan 12Antilymphocyte Serum 11Rituximab 9Etoposide 7Methotrexate 6Cyclosporine 6Melphalan 5thymoglobulin 4Flow Cytometry 4Carboplatin 4Therapeutics 3Radiotherapy 3Lenalidomide 3In Situ Hybridization, Fluorescence 3Immunohistochemistry 3Gene Expression Profiling 3Filgrastim 3Everolimus 3Amplified Fragment Length Polymorphism Analysis 3Alemtuzumab 3fludarabine 2Vorinostat 2Vincristine 2Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphoma, Extranodal NK-T-Cell × Dietary Supplements × Clear all
NCT00365768 2016-09-09

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

Columbia University

Phase 2 Completed
56 enrolled 5 charts
GenitourinaryLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Kidney Neoplasms, Leukemia, Lymphoma, Wilms Tumor, Peripheral Nervous System Diseases, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Neuroectodermal Tumors, Primitive, Peripheral, Neurotoxicity Syndromes, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡